The Manufacturers Life Insurance Company Acquires 65,333 Shares of Stryker Corporation $SYK

The Manufacturers Life Insurance Company boosted its position in shares of Stryker Corporation (NYSE:SYK) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 859,544 shares of the medical technology company’s stock after buying an additional 65,333 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.22% of Stryker worth $270,642,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of SYK. Palogic Value Management L.P. increased its stake in shares of Stryker by 4.3% in the 2nd quarter. Palogic Value Management L.P. now owns 1,313 shares of the medical technology company’s stock valued at $413,000 after buying an additional 54 shares during the period. Tidal Investments LLC lifted its stake in shares of Stryker by 174.2% during the second quarter. Tidal Investments LLC now owns 111,457 shares of the medical technology company’s stock valued at $35,091,000 after acquiring an additional 70,805 shares during the period. Van Hulzen Asset Management LLC boosted its holdings in Stryker by 3.3% in the second quarter. Van Hulzen Asset Management LLC now owns 15,148 shares of the medical technology company’s stock valued at $4,769,000 after acquiring an additional 481 shares during the last quarter. National Pension Service increased its position in Stryker by 2.4% in the second quarter. National Pension Service now owns 721,186 shares of the medical technology company’s stock worth $227,058,000 after purchasing an additional 16,962 shares during the period. Finally, WINTON GROUP Ltd increased its position in Stryker by 129.2% in the second quarter. WINTON GROUP Ltd now owns 31,200 shares of the medical technology company’s stock worth $9,823,000 after purchasing an additional 17,585 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Stryker Stock Down 2.0%

Shares of NYSE SYK opened at $269.98 on Friday. The stock has a market cap of $103.56 billion, a P/E ratio of 27.98, a P/E/G ratio of 1.72 and a beta of 0.76. The firm has a 50 day moving average price of $325.65 and a 200 day moving average price of $326.84. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. Stryker Corporation has a 52-week low of $269.64 and a 52-week high of $392.55.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period last year, the business posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts expect that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.3%. Stryker’s payout ratio is currently 36.48%.

Insiders Place Their Bets

In other news, insider Debra King sold 826 shares of Stryker stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider owned 6,210 shares in the company, valued at $2,088,423. The trade was a 11.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Dylan Crotty sold 441 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 351,267 shares of company stock worth $118,197,701. Corporate insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on SYK. JPMorgan Chase & Co. cut their target price on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, July 31st. BTIG Research dropped their price target on shares of Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research note on Friday, July 31st. Evercore set a $350.00 price objective on shares of Stryker in a report on Monday, July 6th. Argus set a $370.00 target price on shares of Stryker in a report on Thursday, July 9th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. Eighteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $380.40.

Stryker Profile

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker’s principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.